Literature DB >> 29439274

Relation of Paraoxonase 1 Activity with Biochemical Variables, Brachial Artery Intima-Media Thickness in Patients with Diabetes with or without Obesity.

Pinar Karakaya1, Bahar Ozdemir, Meral Mert, Yildiz Okuturlar.   

Abstract

AIM: The sodium-sparing effect of insulin leads to increase in total sodium pool of the body which is a chronic stimulus for atrial natriuretic peptide (ANP). In our study we aimed to determine the relationship between ANP and microvascular complications of diabetes.
METHODS: 60 patients, 30-70 years old, with the diagnosis of type 2 diabetes mellitus (DM) are enrolled into the study. Patients with a chronic disease other than DM are excluded. Blood samples for routine biochemical tests are taken after at least 12 h fasting at 8-9 am. Blood samples for glucose and insulin levels are taken 2 h after a standard meal. Blood tubes with EDTA are used for ANP levels. The microvascular complications of the patients are evaluated.
RESULTS: 32 of the patients had microvascular complications. Age, BMI, waist and hip circumferences, and ANP levels were significantly higher in the group with microvascular complications. There were no significant differences in waist-to-hip ratio, blood glucose, HbA1c, fasting insulin, postprandial insulin, fasting HOMA, postprandial HOMA as well as sodium, potassium, magnesium, calcium and lipid levels between the two groups. When the relationship between ANP and obesity, retinopathy, neuropathy, nephropathy, diabetes time, HbA1c, or sex are evaluated separately, the only significant parameters related to ANP were obesity and retinopathy.
CONCLUSION: In our study we have found that there was a significant relationship between ANP levels and microvascular complications of diabetes. Future studies are needed to show if ANP is the stimulus of microvascular complication development/progression or only an epiphenomenon.
© 2018 The Author(s) Published by S. Karger GmbH, Freiburg.

Entities:  

Keywords:  BMI; Brachial artery intima-media thickness; Cardiometabolic risk; Diabetes mellitus; Obesity; Paraoxonase 1 activity

Mesh:

Substances:

Year:  2018        PMID: 29439274      PMCID: PMC5869602          DOI: 10.1159/000486513

Source DB:  PubMed          Journal:  Obes Facts        ISSN: 1662-4025            Impact factor:   3.942


  39 in total

1.  Minimally oxidised LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy.

Authors:  S Picard; C Talussot; A Serusclat; N Ambrosio; F Berthezène
Journal:  Diabetes Metab       Date:  1996-02       Impact factor: 6.041

2.  Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.

Authors:  Natàlia Ferré; Albert Feliu; Anabel García-Heredia; Judit Marsillach; Neus París; Marta Zaragoza-Jordana; Bharti Mackness; Michael Mackness; Joaquín Escribano; Ricardo Closa-Monasterolo; Jorge Joven; Jordi Camps
Journal:  Clin Biochem       Date:  2013-09-10       Impact factor: 3.281

3.  Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.

Authors:  Sandra Beer; Xenia Moren; Juan Ruiz; Richard W James
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-01-18       Impact factor: 4.222

4.  Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome.

Authors:  Marie-Claude Blatter Garin; Barbara Kalix; Alfredo Morabia; Richard W James
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

5.  Serum paraoxonase enzyme activity and oxidative stress in obese subjects.

Authors:  Mehmet Aslan; Mehmet Horoz; Tevfik Sabuncu; Hakim Celik; Sahbettin Selek
Journal:  Pol Arch Med Wewn       Date:  2011-06

6.  Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease.

Authors:  Leonella Pasqualini; Claudio Cortese; Simona Marchesi; Donatella Siepi; Matteo Pirro; Gaetano Vaudo; Laura Liberatoscioli; Agostino Gnasso; Giuseppe Schillaci; Elmo Mannarino
Journal:  Atherosclerosis       Date:  2005-12       Impact factor: 5.162

7.  Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.

Authors:  Magdalena Kasprzak; Maria Iskra; Wacław Majewski; Tomasz Wielkoszyński
Journal:  Clin Biochem       Date:  2008-10-17       Impact factor: 3.281

8.  Relationship of adiponectin to serum paraoxonase 1.

Authors:  Laszlo Bajnok; Eva Csongradi; Ildiko Seres; Zsuzsa Varga; Sara Jeges; Attila Peti; Zsolt Karanyi; Attila Juhasz; Emese Mezosi; Endre V Nagy; Gyorgy Paragh
Journal:  Atherosclerosis       Date:  2007-07-12       Impact factor: 5.162

9.  Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors.

Authors:  Yumiko Iwamoto; Tatsuya Maruhashi; Yuichi Fujii; Naomi Idei; Noritaka Fujimura; Shinsuke Mikami; Masato Kajikawa; Takeshi Matsumoto; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Yukihito Higashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-12       Impact factor: 8.311

10.  Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Yoshiko Sano; Kokoro Tsuzaki; Yukiyo Matsuoka; Kahori Egawa; Makiko Yoshimura; Chika Horikawa; Yoshinori Kitagawa; Yoshinobu Kiso; Satoshi Kimura; John Schulze; Jennifer Taing; Alejandro Gugliucci
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more
  2 in total

Review 1.  Current perspectives of oleic acid: Regulation of molecular pathways in mitochondrial and endothelial functioning against insulin resistance and diabetes.

Authors:  Kanwal Rehman; Kamran Haider; Komal Jabeen; Muhammad Sajid Hamid Akash
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

2.  Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Nurhan Sarioglu; Cigdem Bilen; Celalettin Cevik; Nahit Gencer
Journal:  Eurasian J Med       Date:  2020-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.